Page last updated: 2024-09-03

sc 51089 and Body Weight

sc 51089 has been researched along with Body Weight in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abe, T; Anrather, J; Iadecola, C; Kunz, A; Shimamura, M; Zhou, P	1

Other Studies

1 other study(ies) available for sc 51089 and Body Weight

Article	Year
The neuroprotective effect of prostaglandin E2 EP1 receptor inhibition has a wide therapeutic window, is sustained in time and is not sexually dimorphic. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2009, Volume: 29, Issue:1 Topics: Animals; Body Weight; Brain Ischemia; Dinoprostone; Dose-Response Relationship, Drug; Female; Hydrazines; Male; Mice; Neuroprotective Agents; Oxazepines; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Sex Characteristics; Time Factors; Treatment Outcome	2009

Article

Year

The neuroprotective effect of prostaglandin E2 EP1 receptor inhibition has a wide therapeutic window, is sustained in time and is not sexually dimorphic.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2009, Volume: 29, Issue:1

Topics: Animals; Body Weight; Brain Ischemia; Dinoprostone; Dose-Response Relationship, Drug; Female; Hydrazines; Male; Mice; Neuroprotective Agents; Oxazepines; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Sex Characteristics; Time Factors; Treatment Outcome

2009